Skip to main content

Michael R Bubb, MD

Rheumatologist (Joints & Arthritis Specialist)

Photo of Michael R Bubb

Research at a glance

Top areas of exploration

  • Actins , 38 publications
  • Microfilament Proteins , 19 publications
  • Amino Acid Sequence , 18 publications
  • Protein Binding , 14 publications

Research activity

89 publications

4,213 citations

Why is this important?

Active clinical trials

FT819-102

This is a phase 1 study designed to evaluate the safety, pharmacokinetics (PK), and anti-B-cell activity of FT819 following treatment with or without auxiliary medicinal product (AMP) in participants with moderate-to-severe active systemic lupus…

Investigator
Michael R Bubb
Status
Accepting Candidates
Ages
12 Years - 70 Years
Sexes
All
CABA-201 for SLE

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Investigator
Michael R Bubb
Status
Accepting Candidates
Ages
18 Years - 65 Years
Sexes
All
NKARTA NKX019-102

This is a Phase 1/2, open-label, multi-center, multi-cohort, non-randomized dose escalation and dose expansion basket study to determine the safety and tolerability of NKX019 (allogeneic CAR NK cells targeting CD19) in participants with autoimmune…

Investigator
Michael R Bubb
Status
Accepting Candidates
Ages
18 Years - 75 Years
Sexes
All

My publications

89 publications

2026

Effect of apremilast on whole-body magnetic resonance imaging of peripheral and axial inflammation in patients with psoriatic arthritis.

Annals of the rheumatic diseases

PubMed Publisher's site

2026

Residual confounding in a study of acetaminophen risk: errors resulting from dichotomized variables: comment on the article by Kaur et al.

Arthritis care & research

PubMed Publisher's site

2026

A case of antineutrophil cytoplasmic antibody-associated vasculitis and sclerosing mediastinitis.

Modern rheumatology case reports

PubMed Publisher's site

2025

Effect of apremilast on hand and whole-body MRI assessments of inflammation in patients with psoriatic arthritis (MOSAIC): a phase 4, multicentre, single-arm, open-label study.

The Lancet. Rheumatology

PubMed Publisher's site